Cargando…

Impact of clinical diagnosis of myocardial infarction in patients with elevated cardiac troponin

OBJECTIVE: Type 2 myocardial infarction (MI) and myocardial injury are common conditions associated with an adverse prognosis. Physicians experience uncertainty how to distinguish these conditions, as well as how to manage and treat them. Therefore, the objective of this study was to compare treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gard, Anton, Lindahl, Bertil, Baron, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579506/ https://www.ncbi.nlm.nih.gov/pubmed/37220934 http://dx.doi.org/10.1136/heartjnl-2022-322298

Ejemplares similares

Interphysician agreement on subclassification of myocardial infarction
por: Gard, Anton, et al.
Publicado: (2018)

Sex differences in investigations and outcomes among patients with type 2 myocardial infarction
por: Kimenai, Dorien M, et al.
Publicado: (2021)

Use of historical high-sensitivity cardiac troponin T levels to rule out myocardial infarction
por: Roos, Andreas, et al.
Publicado: (2021)

Using historical cardiac troponins to identify patients at a high risk of myocardial infarction
por: Roos, Andreas, et al.
Publicado: (2023)

Implementation of an early rule-out pathway for myocardial infarction using a high-sensitivity cardiac troponin T assay
por: Sandeman, Dennis, et al.
Publicado: (2021)

Influence of health-related quality of life on time from symptom onset to hospital arrival and the risk of readmission in patients with myocardial infarction
por: Henriksson, Catrin, et al.
Publicado: (2014)

A decade of changes in clinical characteristics and management of elderly patients with non-ST elevation myocardial infarction admitted in Italian cardiac care units
por: De Luca, Leonardo, et al.
Publicado: (2014)

Clinical outcome of patients with ST‐elevation myocardial infarction and angiographic evidence of coronary artery ectasia
por: Baldi, Cesare, et al.
Publicado: (2021)

Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction
por: Entezarjou, Artin, et al.
Publicado: (2018)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction
por: Pichot, Sophie, et al.
Publicado: (2015)

Outcomes of ischaemic mitral regurgitation in anterior versus inferior ST elevation myocardial infarction
por: Mentias, Amgad, et al.
Publicado: (2016)

Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction
por: Reinstadler, Sebastian Johannes, et al.
Publicado: (2016)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

A nationwide causal mediation analysis of survival following ST-elevation myocardial infarction
por: Dondo, Tatendashe Bernadette, et al.
Publicado: (2020)

COVID-19 pandemic is associated with mechanical complications in patients with ST-elevation myocardial infarction
por: Kitahara, Satoshi, et al.
Publicado: (2021)

Changes in ST segment elevation myocardial infarction hospitalisations in China from 2011 to 2015
por: Zhou, Tianna, et al.
Publicado: (2021)

Prehospital identification of ST-segment elevation myocardial infarction and mortality (ANZACS-QI 61)
por: Liao, Becky Yi-Wen, et al.
Publicado: (2022)

Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021)

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
por: Mohammad, Moman A, et al.
Publicado: (2020)

Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial
por: Testori, Christoph, et al.
Publicado: (2019)

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction
por: Maznyczka, Annette Marie, et al.
Publicado: (2019)

Vessel fractional flow reserve in assessment of non-culprit lesions in ST elevation myocardial infarction
por: Chang, Chun Chin, et al.
Publicado: (2021)

Vall d’Hebron Risk Score II for myocardial infarction and cardiac death
por: Romero-Farina, Guillermo, et al.
Publicado: (2023)

Age-specific gender differences in early mortality following ST-segment elevation myocardial infarction in China
por: Zheng, Xin, et al.
Publicado: (2015)

The clinical value of serial measurement of high-sensitivity cardiac troponin T in acute exacerbations ofchronic obstructive pulmonary disease
por: Høiseth, Arne Didrik, et al.
Publicado: (2014)

Treatment choices in elderly patients with ST: elevation myocardial infarction—insights from the Vital Heart Response registry
por: Toleva, Olga, et al.
Publicado: (2015)

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time
por: Huded, Chetan P., et al.
Publicado: (2020)

Comparison of myocardial microcirculatory perfusion after catheter‐administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST‐elevation myocardial infarction
por: Fu, Yang, et al.
Publicado: (2019)

Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China
por: Song, Jiali, et al.
Publicado: (2021)

Impact of COVID‐19 pandemic on the management of nonculprit lesions in patients presenting with ST‐elevation myocardial infarction: Outcomes from the pan‐London heart attack centers
por: Demir, Ozan M., et al.
Publicado: (2021)

Cardiac α(V)β(3) integrin expression following acute myocardial infarction in humans
por: Jenkins, William S A, et al.
Publicado: (2017)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST‐segment elevation myocardial infarction
por: Savage, Michael L., et al.
Publicado: (2022)

Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials
por: Sykes, Robert, et al.
Publicado: (2021)

Associations between cardiac troponin, mortality and subsequent use of cardiovascular services: differences in sex and ethnicity
por: Winchester, David E, et al.
Publicado: (2018)

Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome
por: Chapman, Andrew R, et al.
Publicado: (2019)

Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018)

Utility of prehospital electrocardiogram interpretation in ST‐segment elevation myocardial infarction utilizing computer interpretation and transmission for interventional cardiologist consultation
por: Faour, Amir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5b9cbtdkgk74lpp7e32dv3dr8d